2-[3-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-oxopropyl]benzoic acid methyl ester
CAS: 149968-11-6
Ref. 3D-FC20041
1mg | A consultar | ||
2mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar |
Informação sobre produto
- Methyl (E)-2-[3-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-oxopropyl]benzoate
- 2-(3-(2-(7-Chloro-2-Quinolinyl)-Ethenyl-Phenyl)-3-Oxo-Propyl)-1-Methoxycarbonylbenzene
- Benzoic acid, 2-[3-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-oxopropyl]-, methyl ester
- Benzoic acid, 2-[3-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-oxopropyl]-, methyl ester, (E)-
- Benzonic acid 2-(3-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-(3-carbonyl)propyl)-methyl ester
- Methyl (E)-2-[3-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-oxopropyl]benzoate
2-[3-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-oxopropyl]benzoic acid methyl ester is a five-membered ring compound. It has organic solvents that can be screened for biological activity using high throughput screening. This compound is insoluble in water and reacts with bases, acids, and other compounds to form salts, benzoates, or crystallizing solids. The molecular conformation of this compound was determined by bioinformatics methods. It is a member of the class of 7-chloroquinoline derivatives that have been shown to inhibit Singulair (montelukast), an asthma drug. These agents are thought to bind to the active site of the enzyme cytochrome P450 and may also inhibit its ability to metabolize drugs such as acetaminophen and phenytoin.
Propriedades químicas
Consulta técnica sobre: 3D-FC20041 2-[3-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-oxopropyl]benzoic acid methyl ester
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.